Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eurobio ScientificSTU:E8TN +0.49%69 EV-to-FCF is 33.07 as of Aug. 05, 2026, which is 870% above its 10-year median of 3.41. GuruFocus rates STU:E8TN with a GF Score™ of 69/100 and a GF Value™ of €25.22 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Eurobio Scientific ranks worse than 63.07% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Eurobio Scientific's Enterprise Value is €207.8 Mil.
Eurobio Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €6.3 Mil. Therefore, Eurobio Scientific's EV-to-FCF for today is 33.07.
The historical rank and industry rank for Eurobio Scientific's EV-to-FCF or its related term are showing as below:
STU:E8TN'
s EV-to-FCF Range Over the Past 10 Years
Min: -39.89 Med: 3.41 Max: 62.32
Current: 32.91
During the past 13 years, the highest EV-to-FCF of Eurobio Scientific was 62.32. The lowest was -39.89. And the median was 3.41.
STU:E8TN's EV-to-FCF is ranked worse than 63.07% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.52
vs STU:E8TN: 32.91
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eurobio Scientific's PE Ratio (TTM) for today is calculated as:
Eurobio Scientific's share price for today is €20.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurobio Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.470.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Eurobio Scientific EV-to-FCF Related Terms
Eurobio Scientific EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Eurobio Scientific's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Eurobio Scientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurobio Scientific EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Eurobio Scientific's EV-to-FCF falls into.
Eurobio Scientific's current Enterprise Value is €207.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurobio Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €6.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurobio Scientific (STU:E8TN) has a EV-to-FCF of 33.07 as of Aug. 05, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Eurobio Scientific and its competitors. This is 870% above median its historical median of 3.41. According to the industry distribution chart, Eurobio Scientific ranks #263 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 63.1%.
Is Eurobio Scientific's EV-to-FCF too high?
Eurobio Scientific's current EV-to-FCF of 33.07 is 870% above median its 10-year median of 3.41. The Medical Devices & Instruments industry median EV-to-FCF is 23.52. Eurobio Scientific's value of 33.07 is 40.6% above this industry median. Based on the distribution chart, Eurobio Scientific ranks #263 out of 417 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eurobio Scientific has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eurobio Scientific's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eurobio Scientific ranks #263 out of 417 companies for EV-to-FCF. This places Eurobio Scientific in the lower half of its industry. The industry median EV-to-FCF is 23.52. Eurobio Scientific's value of 33.07 is 40.6% above this benchmark. While the company's 10-year median is 3.41 vs. the industry median of 23.52, Eurobio Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.52, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurobio Scientific's current EV-to-FCF of 33.07 is 40.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Eurobio Scientific and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurobio Scientific's current EV-to-FCF is 33.07, which is 870% above median its own 10-year median of 3.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurobio Scientific stock overvalued right now?
Based on GuruFocus' analysis, Eurobio Scientific (STU:E8TN) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.22, compared to a current price of €20.40 — trading 19.1% below its estimated fair value. The current EV-to-FCF is 33.07, which is 870% above median its 10-year median of 3.41 and 40.6% above the Medical Devices & Instruments industry median of 23.52. Eurobio Scientific's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Eurobio Scientific (STU:E8TN), the current EV-to-FCF is 33.07 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurobio Scientific (STU:E8TN) Overvalued in 2026?
Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued.
The current stock price of €20.40 is trading 19.1% below its estimated GF Value™ of €25.22.
GuruFocus considers Eurobio Scientific to be Modestly Undervalued.
Key valuation signals for STU:E8TN:
EV-to-FCF: 33.07 (870% above median its 10-year median of 3.41)
GF Value™: €25.22 vs. price of €20.40 (19.1% below fair value)
Industry Position: 40.6% above the Medical Devices & Instruments median (#263 of 417)
No single metric tells the full story. See the STU:E8TN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
69GF Score
Get the complete analysis for STU:E8TN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:E8TN has been successfully added to your 
